Centre Hospitalier de Verdun
- Address
- 2 Rue d’Anthouard, 55100 VERDUN, France
Centre Hospitalier de Verdun - Autoimmune and Vasculitis Research
The Centre Hospitalier de Verdun is actively engaged in advancing therapeutic strategies for complex autoimmune conditions, with particular expertise in the management of systemic vasculitides. The center participates in multicenter clinical research aimed at optimizing long-term treatment protocols for patients with rare and challenging inflammatory diseases.
- ANCA-associated vasculitis remission maintenance strategies
- Corticosteroid tapering protocols in autoimmune disease management
- Rituximab-based immunosuppressive therapy optimization
The center's research portfolio includes comparative studies evaluating extended low-dose prednisone administration in patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). Through rigorous randomized, placebo-controlled trial designs, investigators work to identify optimal maintenance strategies that minimize relapse rates while reducing long-term corticosteroid exposure in patients who have achieved remission with rituximab or other immunosuppressive agents.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Hospices Civils De Lyon1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier de Verdun
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Remission Maintenance with Extended Prednisone Administration in ANCA-Associated Vasculitis Using Rituximab Therapy | Hospices Civils De Lyon | Phase III | Recruiting | Aug 2019 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Microcrystalline Cellulose | 1 | Unknown | 2019-08-20 | 2019-08-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.